SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21044773
Source:
http://linkedlifedata.com/resource/pubmed/id/21044773
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002395
,
umls-concept:C0338656
,
umls-concept:C0936012
pubmed:issue
6
pubmed:dateCreated
2010-11-3
pubmed:abstractText
Numerous patient- and disease-related factors increase the risk of rapid cognitive decline in patients with Alzheimer's disease (AD). The ability of pharmacological treatment to attenuate this risk remains undefined.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101231978
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Indans
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines
,
http://linkedlifedata.com/resource/pubmed/chemical/donepezil
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1552-5279
pubmed:author
pubmed-author:CummingsJeffreyJ
,
pubmed-author:GauthierSergeS
,
pubmed-author:JonesRoyR
,
pubmed-author:LopezOscar LOL
,
pubmed-author:SchindlerRachelR
,
pubmed-author:SchwamEliasE
,
pubmed-author:WaldemarGunhildG
,
pubmed-author:WilkinsonDavidD
,
pubmed-author:ZhangRichardR
pubmed:copyrightInfo
Copyright © 2010 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
431-9
pubmed:meshHeading
pubmed-meshheading:21044773-Aged
,
pubmed-meshheading:21044773-Aged, 80 and over
,
pubmed-meshheading:21044773-Alzheimer Disease
,
pubmed-meshheading:21044773-Cholinesterase Inhibitors
,
pubmed-meshheading:21044773-Cognition Disorders
,
pubmed-meshheading:21044773-Disease Progression
,
pubmed-meshheading:21044773-Female
,
pubmed-meshheading:21044773-Humans
,
pubmed-meshheading:21044773-Indans
,
pubmed-meshheading:21044773-Longitudinal Studies
,
pubmed-meshheading:21044773-Male
,
pubmed-meshheading:21044773-Middle Aged
,
pubmed-meshheading:21044773-Piperidines
,
pubmed-meshheading:21044773-Predictive Value of Tests
,
pubmed-meshheading:21044773-Prognosis
,
pubmed-meshheading:21044773-Randomized Controlled Trials as Topic
,
pubmed-meshheading:21044773-Risk Factors
pubmed:year
2010
pubmed:articleTitle
Predicting cognitive decline in Alzheimer's disease: an integrated analysis.
pubmed:affiliation
Department of Neurology, Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA. lopezol@upmc.edu
pubmed:publicationType
Journal Article
,
Review
,
Research Support, Non-U.S. Gov't